Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanotechnology Company to Announce Breakthroughs

Abstract:
PharmaNova, a leader in nanotechnology-based Drug Delivery Systems, is due to exhibit at the 2009 annual meeting of the American Association of Pharmaceutical Scientists (AAPS) scheduled in Los Angeles, CA, from November 8 - 12.

Nanotechnology Company to Announce Breakthroughs

Victor, NY | Posted on September 30th, 2009

The Company will announce new technology breakthroughs in discussions with visitors to the exhibit. The meeting will be at Los Angeles Convention Center and the booth location is 2451.

NovaSperse(SM) technology is focused on the formation of stable amorphous nanoparticles with excellent reproducibility. This technology is being applied to both New Product Opportunities (NPOs) and Client Sponsored Projects (CSPs).

PharmaNova's proprietary NovaSperse(SM) technology offers proactive control of nanoparticle characteristics and is tailored to the unique chemistry of individual active pharmaceutical ingredients (APIs). PharmaNova's scientists are actively advancing the NovaSperse(SM) technology platform towards attaining a leadership position among nanotechnology-enabled drug delivery companies.

A nanometer is one-billionth of a meter; a human hair is roughly 100,000 nanometers wide; a human fingernail grows 1 nanometer every second; a sheet of paper is about 100,000 nanometers thick.

####

About PharmaNova Inc.
PharmaNova Inc. is a privately held, specialty pharmaceutical company founded on the re-positioning and enhancement of known drugs using its proprietary NovaSperse(SM) nanoparticle technology platform and other complementary drug delivery and formulation technologies. We address low-risk, fast-to-market products in areas of clear medical need and generate revenue from partnering and licensing strategies with commercialization partners worldwide. PharmaNova also provides contractual services for the NovaSperse(SM)-based formulation of client-owned APIs. PharmaNova's pipeline includes a (partnered) non-hormonal treatment for menopausal hot flashes and topical anti-infective and ophthalmic new product opportunities. PharmaNova and Altacor of Cambridge, England, have formed a strategic alliance to develop and commercialize a series of new prescription ophthalmic medical products based on PharmaNova's proprietary NovaSperse(SM) nanoparticle technology.

For more information, please click here

Contacts:
Tom Biviano
Director Business Development
585-413-4721 x102

Copyright © prnewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Synthesize Stable Ceramic Nanopowders at Room Temperature September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

Nanomedicine

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

The Pocket Project will develop a low-cost and accurate point-of-care test to diagnose Tuberculosis: ICN2 holds a follow-up meeting of the Project on September 18th - 19th September 18th, 2014

New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014

Recruiting bacteria to be technology innovation partners: September 17th, 2014

Announcements

Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

Events/Classes

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

IEEE International Electron Devices Meeting To Celebrate 60th Anniversary as The Leading Technical Conference for Advanced Semiconductor Devices September 18th, 2014

PEN Inc. Chairman, Scott Rickert, Will Webcast a Live Company Update September 25, 1 PM EDT September 17th, 2014

Dolomite to launch Meros TCU-100 temperature controller at Lab-on-a-Chip & Microarray World Congress September 15th, 2014

Nanobiotechnology

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

CiQUS researchers design an artificial nose to detect DNA differentiation with single nucleotide resolution September 18th, 2014

Biosensors Get a Boost from Graphene Partnership: $5 Million Investment Supports Dozens of Jobs and Development of 300mm Fabrication Process and Wafer Transfer Facility September 18th, 2014

Recruiting bacteria to be technology innovation partners: September 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE